CAMP4 Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CAMP4 Therapeutics generated cash of $28,585,000, which is more than the previous year. Cash used in financing activities reached the amount of -$27,316,000 last year. Net change in cash is therefore -$12,780,000.
Cash Flow
| 2010 | 2.47M | 215K | -6.75M |
|---|---|---|---|
| 2011 | 857K | -785K | 1.18M |
| 2012 | 12.43M | -510K | -10.56M |
| 2013 | 16.59M | -2.39M | 43.30M |
| 2014 | 22.81M | -64.17M | -2.50M |
| 2016 | 47.4M | -90.67M | 148.47M |
| 2018 | 66.89M | -26.45M | -2.26M |
| 2020 | 11.54M | -65.69M | -94.82M |
| 2021 | 28.58M | -13.69M | -27.31M |
CAMP Cash Flow Statement (2010 – 2021)
| 2021 | 2020 | 2018 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 107.40M | 256.5M | 93.70M | 34.18M | 63.10M | 5.60M | 4.24M | 2.98M | 6.91M |
Operating activities | |||||||||
Net income | -21.15M | -79.30M | 16.61M | 16.94M | 11.80M | 44.62M | 5.21M | -3.28M | -10.85M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 22.00M | 31.98M | 22.95M | 10.20M | 8.10M | 2.76M | 2.44M | 3.07M | 2.52M |
Stock-based compensation expense | 11.36M | 12.42M | 9.29M | 5.85M | 2.92M | 2.91M | 2.37M | 2.10M | 1.98M |
| Deferred income tax benefit | 11.36M | 12.42M | 9.29M | 5.85M | 2.92M | 2.91M | 2.37M | 2.10M | 1.98M |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 1.62M | 9.60M | -6.44M | -1.51M | -11.40M | -4.72M | 2.43M | -294K | -2.78M |
Inventories | 8.69M | 1.01M | -6.51M | 1.93M | -1.30M | -3.45M | -167K | 718K | 4.62M |
Accounts payable | 10.16M | -16.44M | 5.06M | 926K | 7.52M | 2.34M | -4.58M | -2.08M | 10.76M |
Cash generated by operating activities | 28.58M | 11.54M | 66.89M | 47.4M | 22.81M | 16.59M | 12.43M | 857K | 2.47M |
Investing activities | |||||||||
Purchases Of Investments | -6.26M | -19.54M | -38.07M | -78.54M | -9.01M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -11.35M | -22.19M | -8.33M | -4.31M | -2.13M | -1.85M | 0 | 0 | 0 |
Acquisitions Net | -13.03M | -60.65M | 0 | -7.70M | -52.95M | -1M | 0 | 0 | 0 |
Cash generated by investing activities | -13.69M | -65.69M | -26.45M | -90.67M | -64.17M | -2.39M | -510K | -785K | 215K |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 44.78M | 0 | 0 | 3.96M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -49M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -57.59M | -94.68M | 0 | -2.03M | -3.37M | -1.73M | -5M | 0 | -22.72M |
Cash used in financing activities | -27.31M | -94.82M | -2.26M | 148.47M | -2.50M | 43.30M | -10.56M | 1.18M | -6.75M |
Net Change In Cash | -12.78M | -149.09M | 38.89M | 105.20M | -43.86M | 57.5M | 1.36M | 1.25M | -3.92M |
Cash at end of period | 94.62M | 107.40M | 132.60M | 139.38M | 19.23M | 63.10M | 5.60M | 4.24M | 2.98M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |